rs3739022
Positions:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_002299.4(LCT):c.4329C>T(p.Gly1443Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.121 in 1,613,826 control chromosomes in the GnomAD database, including 16,407 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.16 ( 2414 hom., cov: 32)
Exomes 𝑓: 0.12 ( 13993 hom. )
Consequence
LCT
NM_002299.4 synonymous
NM_002299.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -3.48
Genes affected
LCT (HGNC:6530): (lactase) The protein encoded by this gene belongs to the glycosyl hydrolase 1 family of proteins. The encoded preproprotein is proteolytically processed to generate the mature enzyme. This enzyme is integral to the plasma membrane and has both phlorizin hydrolase activity and lactase activity. Mutations in this gene are associated with congenital lactase deficiency. Polymorphisms in this gene are associated with lactase persistence, in which intestinal lactase activity persists at childhood levels into adulthood. [provided by RefSeq, Jan 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BP6
Variant 2-135804902-G-A is Benign according to our data. Variant chr2-135804902-G-A is described in ClinVar as [Benign]. Clinvar id is 331176.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-135804902-G-A is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-3.48 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.319 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LCT | NM_002299.4 | c.4329C>T | p.Gly1443Gly | synonymous_variant | 10/17 | ENST00000264162.7 | NP_002290.2 | |
LCT | XM_017004088.3 | c.4329C>T | p.Gly1443Gly | synonymous_variant | 10/15 | XP_016859577.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LCT | ENST00000264162.7 | c.4329C>T | p.Gly1443Gly | synonymous_variant | 10/17 | 1 | NM_002299.4 | ENSP00000264162.2 | ||
LCT | ENST00000452974.1 | n.2625C>T | non_coding_transcript_exon_variant | 4/7 | 1 | ENSP00000391231.1 |
Frequencies
GnomAD3 genomes AF: 0.161 AC: 24529AN: 151962Hom.: 2414 Cov.: 32
GnomAD3 genomes
AF:
AC:
24529
AN:
151962
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.169 AC: 42525AN: 251266Hom.: 4628 AF XY: 0.171 AC XY: 23225AN XY: 135816
GnomAD3 exomes
AF:
AC:
42525
AN:
251266
Hom.:
AF XY:
AC XY:
23225
AN XY:
135816
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.117 AC: 170360AN: 1461746Hom.: 13993 Cov.: 34 AF XY: 0.122 AC XY: 88927AN XY: 727164
GnomAD4 exome
AF:
AC:
170360
AN:
1461746
Hom.:
Cov.:
34
AF XY:
AC XY:
88927
AN XY:
727164
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.161 AC: 24560AN: 152080Hom.: 2414 Cov.: 32 AF XY: 0.170 AC XY: 12615AN XY: 74336
GnomAD4 genome
AF:
AC:
24560
AN:
152080
Hom.:
Cov.:
32
AF XY:
AC XY:
12615
AN XY:
74336
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1026
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 09, 2021 | - - |
Lactose intolerance Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Congenital lactase deficiency Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at